a Stem Cell Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.
b Department of Medical Biotechnology, Faculty of Advanced Medical Sciences , Tabriz University of Medical Sciences , Tabriz , Iran.
Artif Cells Nanomed Biotechnol. 2017 Nov;45(7):1255-1271. doi: 10.1080/21691401.2016.1246452. Epub 2016 Nov 3.
Recent evidence suggests that mesenchymal stem cells (MSCs) have promising therapeutic potential for a broad range of diseases. Because the percentage of MSCs obtained from tissues is very low for cell therapy applications, ex vivo expansion of MSCs is necessary, but aging, loss of stemness and undesired differentiation of them during in vitro cultivation reduces their effectiveness. For achieving ideal therapeutic potential of MSCs in tissue regenerative purposes, it is necessary to retain their stemness properties in vitro. This review emphasis on the last updates in preserving the self-renewal capability of stem cells through in vitro expansion with different parameters.
最近的证据表明,间充质干细胞(MSCs)在广泛的疾病治疗方面具有很大的潜力。由于用于细胞治疗应用的组织中获得的 MSCs 百分比非常低,因此需要进行体外扩增,但在体外培养过程中,它们的老化、干性丧失和不期望的分化会降低其效果。为了在组织再生目的中实现 MSCs 的理想治疗潜力,有必要在体外保留其干性特性。这篇综述重点介绍了通过不同参数的体外扩增来保持干细胞自我更新能力的最新进展。